[LPS].
Miyaura
Chisato
C
Department of Biochemistry, School of Pharmacy, Tokyo University of Pharmacy and Life Science.
D000818:Animals; D001862:Bone Resorption / Q000209:etiology*; D002454:Cell Differentiation / Q000235:genetics / Q000502:physiology; D016207:Cytokines / Q000502:physiology; D006023:Glycoproteins / Q000502:physiology; D006801:Humans; D008070:Lipopolysaccharides; D008262:Macrophage Activation; D008562:Membrane Glycoproteins / Q000502:physiology; D010006:Osteoblasts / Q000502:physiology; D010010:Osteoclasts / Q000166:cytology; D053244:Osteoprotegerin; D011458:Prostaglandins E / Q000502:physiology; D011956:Receptors, Cell Surface / Q000502:physiology; D018160:Receptors, Cytoplasmic and Nuclear / Q000502:physiology; D018124:Receptors, Tumor Necrosis Factor; D051193:Toll-Like Receptors
D016207:Cytokines; D006023:Glycoproteins; D008070:Lipopolysaccharides; D008562:Membrane Glycoproteins; D053244:Osteoprotegerin; D011458:Prostaglandins E; D011956:Receptors, Cell Surface; D018160:Receptors, Cytoplasmic and Nuclear; D018124:Receptors, Tumor Necrosis Factor; C506030:TNFRSF11B protein, human; D051193:Toll-Like Receptors